ARYx Therapeutics, Inc.
2255 Martin Avenue, Suite F
Santa Clara
California
95050
United States
Tel: 408-869-2761
Fax: 408-869-2773
Website: http://www.aryx.com/
Email: info@aryx.com
65 articles about ARYx Therapeutics, Inc.
-
ARYx Therapeutics, Inc. Informed of Additional Delay by FDA and Begins Wind-Down of Operations
3/10/2011
-
ARYx Therapeutics, Inc. Clarifies Current Status of Operations
12/27/2010
-
ARYx Therapeutics, Inc. to Transfer to the NASDAQ Capital Market
12/21/2010
-
ARYx Therapeutics, Inc. Fails to Obtain Financing; Company Restructures and Terminates All Current Employees and Officers
12/17/2010
-
ARYx Therapeutics, Inc. Receives NASDAQ Notice of Non-Compliance
10/11/2010
-
ARYx Therapeutics, Inc. Secures Interim Financing of $6.3 Million; Should Allow ARYx To Operate Through End of 2010
8/16/2010
-
ARYx Therapeutics, Inc. Announces Resignation of Peter G. Milner, President Research and Development
6/3/2010
-
ARYx Therapeutics, Inc. Reports First Quarter 2010 Results of Operations
5/13/2010
-
ARYx Therapeutics, Inc. Schedules First Quarter 2010 Results Conference Call
5/5/2010
-
ARYx Therapeutics, Inc. Reports Fourth Quarter and Full Year 2009 Results of Operations
3/29/2010
-
ARYx Therapeutics, Inc. to Present at Cowen and Company Annual Health Care Conference
3/4/2010
-
ARYx Therapeutics, Inc. Retains Cowen and Company To Explore Strategic Options
2/19/2010
-
ARYx Therapeutics, Inc. Cuts Jobs; Exploring Options After Licensing Talks End
2/19/2010
-
ARYx Therapeutics, Inc. Says FDA Backs Anticlotting Agent Development Path
1/5/2010
-
ARYx Therapeutics, Inc.: Results From Phase 2b Study on Atrial Fibrillation Agent Reviewed at American Heart Association
11/18/2009
-
ARYx Therapeutics, Inc. Reports Third Quarter 2009 Results
11/12/2009
-
ARYx Therapeutics, Inc. Schedules Third Quarter 2009 Results Conference Call
11/5/2009
-
ARYx Therapeutics, Inc. to Present at the Oppenheimer Annual Healthcare Conference
10/30/2009
-
ARYx Therapeutics, Inc. Aligns Operations to Development Activities; Company to Cut Staff
10/29/2009
-
ARYx Therapeutics, Inc. Secures $35 Million Committed Equity Financing Facility
10/7/2009